Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2−/− animals
Open Access
- 1 December 2020
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 13 (12)
Abstract
Alcoholic hepatitis (AH) is the dramatic acute presentation of alcoholic liver disease, with a 15% mortality rate within 28 days in severe cases. Research into AH has been hampered by the lack of effective and reproducible murine models that can be operated under different regulatory frameworks internationally. The liquid Lieber-deCarli (LdC) diet has been used as a means of ad libitum delivery of alcohol but without any additional insult, and is associated with relatively mild liver injury. The transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2) protects against oxidative stress, and mice deficient in this molecule are suggested to be more sensitive to alcohol-induced injury. We have established a novel model of AH in mice and compared the nature of liver injury in C57/BL6 wild-type (WT) versus Nrf2−/− mice. Our data showed that both WT and Nrf2−/− mice demonstrate robust weight loss, and an increase in serum transaminase, steatosis and hepatic inflammation when exposed to diet and ethanol. This is accompanied by an increase in peripheral blood and hepatic myeloid cell populations, fibrogenic response and compensatory hepatocyte regeneration. We also noted characteristic disturbances in hepatic carbohydrate and lipid metabolism. Importantly, use of Nrf2−/− mice did not increase hepatic injury responses in our hands, and female WT mice exhibited a more-reproducible response. Thus, we have demonstrated that this simple murine model of AH can be used to induce an injury that recreates many of the key human features of AH – without the need for challenging surgical procedures to administer ethanol. This will be valuable for understanding of the pathogenesis of AH, for testing new therapeutic treatments or devising metabolic approaches to manage patients whilst in medical care. This article has an associated First Person interview with the joint first authors of the paper.Keywords
Funding Information
- Medical Research Council (MR-S001581, MR/R014019/1)
- British Society of Gastroenterology
- Guts UK
- EUROPOL-ITN (H2020-MSCA-ITN-2014-642773)
This publication has 67 references indexed in Scilit:
- Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumorsFrontiers in Genetics, 2013
- The Type of Dietary Fat Modulates Intestinal Tight Junction Integrity, Gut Permeability, and Hepatic Toll‐Like Receptor Expression in a Mouse Model of Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 2011
- Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3Hepatology, 2010
- Nuclear Factor-Eythroid 2–Related Factor 2 Prevents Alcohol-Induced Fulminant Liver InjuryGastroenterology, 2008
- Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activationAlcohol, 2007
- Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding modelJournal of Hepatology, 2006
- Corticosteroids for alcoholic hepatitis—what's next?Journal of Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Mallory bodies revisitedJournal of Hepatology, 2000
- Severe and Progressive Steatosis and Focal Necrosis in Rat Liver Induced by Continuous Intragastric Infusion of Ethanol and Low Fat DietHepatology, 1985